Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
43,056,667
-
Total 13F shares
-
35,815,470
-
Share change
-
+2,612,954
-
Total reported value
-
$379,143,636
-
Put/Call ratio
-
28%
-
Price per share
-
$10.58
-
Number of holders
-
76
-
Value change
-
+$27,699,133
-
Number of buys
-
31
-
Number of sells
-
32
Institutional Holders of Repare Therapeutics Inc. - Common Shares, no par value (RPTX) as of Q2 2023
As of 30 Jun 2023,
Repare Therapeutics Inc. - Common Shares, no par value (RPTX) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,815,470 shares.
The largest 10 holders included
BVF INC/IL, ORBIMED ADVISORS LLC, CHI Advisors LLC, Deep Track Capital, LP, Versant Venture Management, LLC, ARK Investment Management LLC, Redmile Group, LLC, MPM ASSET MANAGEMENT LLC, T. Rowe Price Investment Management, Inc., and BIOIMPACT CAPITAL LLC.
This page lists
77
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.